(Q46938617)

26 December 2017

title

Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine (English)

1 reference

26 December 2017

1 reference

Edwin V Oaks

1

1 reference

26 December 2017

K Ross Turbyfill

series ordinal

2

1 reference

26 December 2017

language of work or name

English

0 references

publication date

5 December 2005

1 reference

26 December 2017

published in

Vaccine

1 reference

26 December 2017

volume

24

1 reference

26 December 2017

issue

13

1 reference

26 December 2017

page(s)

2290-2301

1 reference

26 December 2017

Transient increase in diarrheal diseases after the devastating earthquake in Kocaeli, Turkey: results of an infectious disease surveillance study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Gastroenteritis in US Marines during Operation Iraqi Freedom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Shigella flexneri infection: pathogenesis and vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

7 January 2021

Meningococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Immunogenicity of a 26-valent group A streptococcal vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

7 January 2021

Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

7 January 2021

Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

7 January 2021

Detection and differentiation of iron-responsive avirulent mutants on Congo red agar

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

7 January 2021

Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

7 January 2021

Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.040

7 January 2021

10.1016/J.VACCINE.2005.11.040

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017